IndraLab

Statements

USP22 deubiquitinates HIF1A. 2 / 3
1 | 2
reach
"A new study reveals that USP22 promotes the pathological process of myocardial hypertrophy by deubiquitinating HIF-1a and further activate the TAK1-(JNK1/2)/P38 signaling pathway [75]."
40102846
reach
"USP22 promotes the pathological process of myocardial hypertrophy by deubiquitinating HIF-1a which further activate the TAK1-(JNK1/2)/p38 signaling pathway [75]."
40102846